Cargando…
Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer
BACKGROUND: Gastric cancer continues to be one of the deadliest cancers in the world and therefore identification of new drugs targeting this type of cancer is thus of significant importance. The purpose of this study was to identify and validate a therapeutic agent which might improve the outcomes...
Autores principales: | Claerhout, Sofie, Lim, Jae Yun, Choi, Woonyoung, Park, Yun-Yong, Kim, KyoungHyun, Kim, Sang-Bae, Lee, Ju-Seog, Mills, Gordon B., Cho, Jae Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170379/ https://www.ncbi.nlm.nih.gov/pubmed/21931799 http://dx.doi.org/10.1371/journal.pone.0024662 |
Ejemplares similares
-
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer
por: Park, Yun-Yong, et al.
Publicado: (2012) -
A curated census of autophagy-modulating proteins and small molecules: Candidate targets for cancer therapy
por: Lorenzi, Philip L, et al.
Publicado: (2014) -
Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma
por: Kang, Dong Woo, et al.
Publicado: (2020) -
Development and Validation of a Prognostic Gene-Expression Signature for Lung Adenocarcinoma
por: Park, Yun-Yong, et al.
Publicado: (2012) -
Vorinostat—An Overview
por: Bubna, Aditya Kumar
Publicado: (2015)